| The challenge of urinary tract infections in renal transplant recipients |
11 |
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study |
11 |
| Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature |
10 |
| Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review |
10 |
| Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review |
10 |
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort |
9 |
| Successful treatment of Ureaplasma-induced hyperammonemia syndrome post-lung transplant |
9 |
| Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation) |
9 |
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study |
8 |
| Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016 |
8 |
| Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation |
7 |
| Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations |
7 |
| Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion |
7 |
| Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia |
7 |
| Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes |
7 |
| Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation |
7 |
| Ureaplasma and Mycoplasma in kidney allograft recipients-A case series and review of the literature |
7 |
| Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections |
7 |
| The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation |
6 |
| Stewardship opportunities in viral pneumonia: Why not the immunocompromised? |
6 |
| Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients |
6 |
| Guillain-Barre syndrome post renal transplant: A systematic review |
6 |
| Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant |
6 |
| A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study |
6 |
| Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease |
6 |
| Association between the time after transplantation and different immunosuppressive medications with dental and periodontal treatment need in patients after solid organ transplantation |
6 |
| Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study |
5 |
| Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection |
5 |
| Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study |
5 |
| Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience |
5 |
| Impact of donor lung pathogenic bacteria on patient outcomes in the immediate posttransplant period |
5 |
| Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies |
5 |
| Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study |
5 |
| Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients |
5 |
| Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology |
5 |
| Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients |
5 |
| Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients |
5 |
| Bacterial infections in pediatric patients during early post liver transplant period: A prospective study in Iran |
5 |
| Fatal disseminated visceral varicella zoster virus infection in a renal transplant recipient |
5 |
| Nocardia infections in the transplanted host |
5 |
| Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer |
5 |
| Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study |
5 |
| A randomized clinical trial comparing Nitrofurazone-coated and uncoated urinary catheters in kidney transplant recipients: Results from a pilot study |
4 |
| Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection |
4 |
| Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up |
4 |
| Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
4 |
| Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients |
4 |
| An unusual case of Nocardia cyriacigeorgica presenting with spinal abscesses in a renal transplant recipient and a review of the literature |
4 |
| Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial |
4 |
| The burden of sinus disease in cystic fibrosis lung transplant recipients |
4 |
